Philip Kantoff, Convergent Therapeutics CEO

May 3, 2023 08:35 AM EDT

Radioantibody startup led by prostate cancer experts raises $90M

Lei Lei Wu

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

Volastra unveils first human data of its solid tumor drug target

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

Roche confirms overall survival benefit for PI3K inhibitor in breast cancer

The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?